Vimta Labs Limited

NSE VIMTALABS.NS

Vimta Labs Limited Return on Capital Employed (ROCE) for the year ending March 31, 2024: 16.31%

Vimta Labs Limited Return on Capital Employed (ROCE) is 16.31% for the year ending March 31, 2024, a -23.49% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.

Vimta Labs Limited Return on Capital Employed (ROCE) for the year ending March 31, 2023 was 21.32%, a -2.85% change year over year.
Vimta Labs Limited Return on Capital Employed (ROCE) for the year ending March 31, 2022 was 21.95%, a 57.79% change year over year.
Vimta Labs Limited Return on Capital Employed (ROCE) for the year ending March 31, 2021 was 13.91%, a 176.85% change year over year.
Vimta Labs Limited Return on Capital Employed (ROCE) for the year ending March 31, 2020 was 5.02%, a -74.59% change year over year.

Key data

Date	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio	Return on Common Equity

NSE: VIMTALABS.NS

Vimta Labs Limited

CEO	Dr. Sivalinga Prasad Vasireddi
IPO Date	Dec. 15, 2005
Location	India
Headquarters	Plot Nos. 141/2 & 142, IDA, Phase II
Employees	1,428
Sector	Healthcare
Industries Telehealth Biotechnology Clinical Trials Pharmaceuticals Research & Consulting

Description

Vimta Labs Limited provides contract research and testing services in India and internationally. It offers laboratory, food and water testing and analysis, preclinical and clinical research, biological molecule structural and functional analysis, environmental assessment, and clinical reference laboratory services. The company serves pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, and various other industries. Vimta Labs Limited was founded in 1984 and is headquartered in Hyderabad, India.

Key trends

Past 5 years